The United States of America as represented by the Secretary of the Army

États‑Unis d’Amérique

Retour au propriétaire

1-20 de 20 pour The United States of America as represented by the Secretary of the Army Trier par
Recheche Texte
Brevet
Canada - CIPO
Affiner par Reset Report
Date
2024 1
2023 1
2022 2
2021 4
Avant 2020 12
Classe IPC
A61P 31/14 - Antiviraux pour le traitement des virus ARN 4
C07K 16/10 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de virus de virus à ARN 3
A61B 17/132 - Tourniquets 2
A61K 39/42 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire viraux 2
C07K 14/18 - Togaviridae, p. ex. flavivirus, virus de la peste, virus de la fièvre jaune, virus de l'hépatite C, virus de l'encéphalite japonaise 2
Voir plus
Statut
En Instance 11
Enregistré / En vigueur 9
Résultats pour  brevets

1.

VACCINES AGAINST CORONAVIRUSES

      
Numéro de document 03265295
Statut En instance
Date de dépôt 2023-08-18
Date de disponibilité au public 2024-02-29
Propriétaire
  • UNITED STATES OF AMERICA, as represented BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (USA)
  • SANOFI PASTEUR INC. (USA)
  • THE GOVERNMENT OF THE UNITED STATES, as represented BY THE SECRETARY OF THE ARMY (USA)
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
Inventeur(s)
  • Joyce, Michael Gordon
  • Modjarrad, Kayvon
  • Thomas, Paul
  • Chen, Wei-Hung
  • Hajduczki, Agnes
  • Rolland, Morgane
  • Lewitus, Eric
  • Anosova, Natalie
  • Clark, Nicholas
  • Davidson, Philip
  • Lecouturier, Valerie
  • Ustyugova, Irina V.
  • Warren, William
  • Wu, Monica Z.
  • Douek, Daniel
  • Koup, Richard

Classes IPC  ?

2.

IGA MONOCLONAL ANTIBODIES FOR TREATING FLAVIVIRUS INFECTION

      
Numéro de document 03229487
Statut En instance
Date de dépôt 2022-08-22
Date de disponibilité au public 2023-02-23
Propriétaire
  • THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (USA)
  • THE GOVERNMENT OF THE UNITED STATES, (USA)
Inventeur(s)
  • Waickman, Adam
  • Wegman, Adam
  • Currier, Jeffrey
  • Friberg, Heather
  • Mccracken, Michael
  • Gromowski, Gregory

Abrégé

The present disclosure relates to IgA antibodies and antigen binding fragments thereof and to cocktails of antibodies and antigen binding fragments that neutralize virus infection without contributing to antibody-dependent enhancement of dengue virus infection. The present disclosure also relates to immortalized B cells that produce, and to epitopes that bind to, such antibodies and antigen binding fragments.

Classes IPC  ?

  • A61P 31/14 - Antiviraux pour le traitement des virus ARN
  • C07K 14/18 - Togaviridae, p. ex. flavivirus, virus de la peste, virus de la fièvre jaune, virus de l'hépatite C, virus de l'encéphalite japonaise
  • C07K 16/10 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de virus de virus à ARN

3.

MONOCLONAL ANTIBODIES AGAINST CORONAVIRUSES AND USES THEREOF

      
Numéro de document 03203325
Statut En instance
Date de dépôt 2022-01-24
Date de disponibilité au public 2022-07-28
Propriétaire
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
Inventeur(s)
  • Krebs, Shelly
  • Modjarrad, Kayvon
  • Michael, Nelson
  • Dussupt, Vincent
  • Donofrio, Gina C.
  • Townsley, Samantha

Abrégé

The present disclosure is directed to monoclonal antibodies, or antigen-binding fragments thereof, that bind to coronavirus spike proteins, including the spike protein of SARS-CoV-2. These antibodies demonstrate high affinity binding to epitopes on the coronavirus spike protein and/or broad cross-reactivity to the spike protein of various coronaviruses. Compositions comprising the anti-coronavirus antibodies, nucleic acids encoding for the antibodies, recombinant expression vectors, and host cells are also disclosed. The present disclosure is also directed to methods of diagnosing, preventing or treating coronavirus infections, including infections or disease caused by SARS-CoV-2.

Classes IPC  ?

  • A61K 39/42 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire viraux
  • A61P 31/14 - Antiviraux pour le traitement des virus ARN
  • C07K 16/10 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de virus de virus à ARN
  • C07K 16/46 - Immunoglobulines hybrides
  • C12N 15/13 - Immunoglobulines
  • G01N 33/577 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet faisant intervenir des anticorps monoclonaux

4.

THERMOGENIC AIRWAY MANAGEMENT DEVICE AND METHODS

      
Numéro de document 03200085
Statut En instance
Date de dépôt 2021-11-30
Date de disponibilité au public 2022-06-09
Propriétaire THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventeur(s)
  • Pierce, Bradley T.
  • Stevens, Ryan A.
  • Tilley, Laura C.

Abrégé

A thermogenic emergency airway management device configured to prevent or treat hypothermia in a patient. The device may be configured to receive ambient air and modify one or more properties of the ambient air to output air at a temperature and/or humidity associated with the prevention and/or treatment of hypothermia. In an embodiment, the device may receive input via a user interface to determine a temperature and/or humidity associated with the air to be output to the patient. In an embodiment, the input may additionally include an amount of air to be output to be the patient. In such an embodiment, the device may be configured to cause the amount of air to be output to the patient to prevent and/or treat hypothermia.

Classes IPC  ?

  • A61M 16/10 - Préparation de gaz ou vapeurs à respirer
  • A61M 16/12 - Préparation de gaz ou vapeurs à respirer par mélange de gaz différents
  • A61M 16/20 - Valves spécialement adaptées aux dispositifs respiratoires médicaux

5.

CATHEPSIN INHIBITORS FOR PREVENTING OR TREATING VIRAL INFECTIONS

      
Numéro de document 03173172
Statut En instance
Date de dépôt 2021-03-26
Date de disponibilité au public 2021-09-30
Propriétaire
  • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (Royaume‑Uni)
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventeur(s)
  • Kane, Christopher D.
  • Soloveva, Veronica
  • Bavari, Sina
  • Peat, Andrew James

Abrégé

Provided are cathepsin inhibitor compounds and pharmaceutically acceptable salts thereof, and combinations thereof, for use in the treatment or prophylaxis of viral disease in an animal.

Classes IPC  ?

  • A61K 31/55 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole
  • A61P 31/14 - Antiviraux pour le traitement des virus ARN

6.

VACCINES AGAINST SARS-COV-2 AND OTHER CORONAVIRUSES

      
Numéro de document 03170575
Statut En instance
Date de dépôt 2021-03-08
Date de disponibilité au public 2021-09-10
Propriétaire
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
Inventeur(s)
  • Joyce, Michael Gordon
  • Modjarrad, Kayvon

Abrégé

The present disclosure relates to the field of vaccines and binding molecules, as well as preparations and methods of their use in the treatment and/or prevention of disease. Described are vaccines and binding molecules, compositions containing the same, and uses thereof for treating or preventing coronavirus infections, in particular, ?-coronaviruses such as SARS- CoV-2, the causative agent of COVID-19, as well as SARS-CoV-1 and other coronaviruses.

Classes IPC  ?

  • A61K 39/215 - Coronaviridae, p. ex. virus de la bronchite infectieuse aviaire

7.

FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINE

      
Numéro de document 03167691
Statut En instance
Date de dépôt 2021-01-13
Date de disponibilité au public 2021-07-22
Propriétaire
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (USA)
Inventeur(s)
  • Torres, Oscar
  • Matyas, Gary R.
  • Rice, Kenner C.
  • Bow, Eric W.
  • Sulima, Agnieszka
  • Jacobson, Arthur E.

Abrégé

Described is the preparation of novel fentanyl haptens of Formula (1) through (6) and their use in the preparation of effective fentanyl vaccines.

Classes IPC  ?

  • A61K 31/4468 - Pipéridines non condensées, p. ex. pipérocaïne ayant un atome d'azote lié directement en position 4, p. ex. clébopride, fentanyl
  • A61P 25/36 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance aux opiacés
  • C07D 211/06 - Composés hétérocycliques contenant des cycles pyridiques hydrogénés, non condensés avec d'autres cycles avec uniquement des atomes d'hydrogène et de carbone liés directement à l'atome d'azote du cycle ne comportant pas de liaison double entre chaînons cycliques ou entre chaînons cycliques et chaînons non cycliques
  • C07D 211/58 - Atomes d'azote liés en position 4

8.

HEMOGLOBIN SUBSTITUTE MIXTURES INCLUDING RECONSTITUTED PLASMA AND PLATELETS AND THEIR MANUFACTURE AND USE

      
Numéro de document 03143968
Statut En instance
Date de dépôt 2020-07-02
Date de disponibilité au public 2021-02-25
Propriétaire
  • HBO2 THERAPEUTICS, LLC (USA)
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventeur(s)
  • Dube, Gregory P.
  • Cap, Andrew P.
  • Meledeo, Michael A.

Abrégé

A therapeutic hemoglobin-based oxygen carrier solution is formed by directly combining at least one of freeze-dried platelets and freeze-drug plasma with a hemoglobin-based oxygen carrier. The therapeutic hemoglobin-based oxygen carrier solution can be employed to treat bleeding or anemia and simultaneously increase systemic convective oxygen delivery in a subject suffering low circulatory oxygen transport or bleeding.

Classes IPC  ?

  • A61K 35/16 - Plasma sanguinSérum sanguin
  • A61K 35/19 - PlaquettesMégacaryocytes
  • A61K 38/42 - HémoglobinesMyoglobines
  • A61K 47/02 - Composés inorganiques
  • A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides
  • A61K 47/18 - AminesAmidesUréesComposés d’ammonium quaternaireAcides aminésOligopeptides ayant jusqu’à cinq acides aminés
  • A61P 7/00 - Médicaments pour le traitement des troubles du sang ou du fluide extracellulaire
  • A61P 7/04 - AntihémorragiquesProfacteurs de coagulationAgents hémostatiquesAgents antifibrinolytiques
  • A61P 7/06 - Antianémiques
  • A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale

9.

POTENT ZIKA VIRUS-SPECIFIC AND CROSS-NEUTRALIZING MONOCLONAL ANTIBODIES TO ZIKA AND DENGUE VIRUSES FOLLOWING ZIKV INFECTION OR VACCINATION

      
Numéro de document 03098373
Statut En instance
Date de dépôt 2019-04-24
Date de disponibilité au public 2019-10-31
Propriétaire
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
  • THE BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (USA)
  • THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventeur(s)
  • Krebs, Shelly
  • Donofrio, Gina
  • Dussupt, Vincent
  • Modjarrad, Kayvon
  • Barouch, Dan
  • Jarman, Iii, Richard G.
  • Michael, Nelson L.
  • Joyce, Gordon
  • Sankhala, Rajeshwer Singh
  • Stephenson, Kathryn Elaine

Abrégé

The invention described herein provides antibodies to Zika virus. The novel polypeptides are useful alone or as portions of larger molecules, such as antibodies or antibody fragments, that can be used to treat or prevent infection of Zika virus.

Classes IPC  ?

  • A61K 39/42 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire viraux
  • A61P 31/14 - Antiviraux pour le traitement des virus ARN
  • C07K 1/22 - Chromatographie d'affinité ou techniques analogues basées sur des procédés d'absorption sélective
  • C07K 14/18 - Togaviridae, p. ex. flavivirus, virus de la peste, virus de la fièvre jaune, virus de l'hépatite C, virus de l'encéphalite japonaise
  • C07K 16/10 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de virus de virus à ARN
  • C07K 16/46 - Immunoglobulines hybrides
  • C12N 7/00 - Virus, p. ex. bactériophagesCompositions les contenantLeur préparation ou purification
  • C12N 15/13 - Immunoglobulines
  • C12P 21/08 - Anticorps monoclonaux
  • G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus

10.

ALUMINUM BASED NANOGALVANIC COMPOSITIONS USEFUL FOR GENERATING HYDROGEN GAS AND LOW TEMPERATURE PROCESSING THEREOF

      
Numéro de document 03070221
Statut Délivré - en vigueur
Date de dépôt 2018-07-23
Date de disponibilité au public 2019-01-31
Date d'octroi 2023-10-10
Propriétaire UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventeur(s)
  • Darling, Kristopher Allen
  • Giri, Anit Kumar
  • Hornbuckle, Billy Chad
  • Roberts, Anthony James
  • Grendahl, Scott Martin

Abrégé

Alloys comprised of a refined microstructure, ultrafine or nano scaled, that when reacted with water or any liquid containing water will spontaneously and rapidly produce hydrogen at ambient or elevated temperature are described. These metals, termed here as aluminum based nanogalvanic alloys will have applications that include but are not limited to energy generation on demand. The alloys may be composed of primarily aluminum and other metals e.g. tin bismuth, indium, gallium, lead, etc. and/or carbon, and mixtures and alloys thereof. The alloys may be processed by ball milling for the purpose of synthesizing powder feed stocks, in which each powder particle will have the above mentioned characteristics. These powders can be used in their inherent form or consolidated using commercially available techniques for the purpose of manufacturing useful functional components.

Classes IPC  ?

  • C22C 21/00 - Alliages à base d'aluminium
  • E21B 23/06 - Appareils pour déplacer, mettre en place, verrouiller, libérer ou retirer, les outils, les packers ou autres éléments dans les trous de forage pour le montage des packers
  • E21B 33/12 - PackersBouchons

11.

METHOD OF CREATING A FRAGMENTATION PATTERN ON A WARHEAD

      
Numéro de document 03018478
Statut En instance
Date de dépôt 2017-03-29
Date de disponibilité au public 2017-10-05
Propriétaire U.S. GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventeur(s)
  • Manz, Paul C.
  • Magnotti, Phillip J.
  • Nguyen, Ductri H.

Abrégé

A method of creating a fragmentation pattern on a warhead comprising ablating material from the interior surface of the warhead according to a pre-defined fragmentation pattern. The pre-defined fragmentation pattern may be effected electronically or with a mask. The ablation may be effected by applying an etchant to the warhead interior surface material.

Classes IPC  ?

  • F42B 12/24 - Projectiles ou mines caractérisés par la charge militaire, l'effet recherché ou le matériau caractérisés par la nature de la charge militaire ou par l'effet recherché du type à explosif brisant à structure de corps de fragmentation l'enveloppe du projectile présentant des rainures, des cannelures ou d'autres affaiblissements
  • F42B 12/32 - Projectiles ou mines caractérisés par la charge militaire, l'effet recherché ou le matériau caractérisés par la nature de la charge militaire ou par l'effet recherché du type à explosif brisant à structure de corps de fragmentation l'enveloppe ou la paroi du projectile contenant un ensemble de corps individuels encastrés, p. ex. de sphères en acier
  • F42B 33/00 - Fabrication de munitionsDémontage de munitionsAppareils à cet effet

12.

OMNIDIRECTIONAL ANTENNA SYSTEM

      
Numéro de document 02923240
Statut Délivré - en vigueur
Date de dépôt 2016-03-08
Date de disponibilité au public 2016-12-04
Date d'octroi 2021-04-20
Propriétaire
  • THE BOEING COMPANY (USA)
  • GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventeur(s)
  • Lavin, Ronald O.
  • Lee, Andy H.
  • Pyle, Glenn T.
  • Robeson, Mark E.

Abrégé

An antenna system may include a first antenna, and a second antenna opposite the first antenna, wherein the first antenna and the second antenna are configured to provide omnidirectional coverage

Classes IPC  ?

  • B64G 1/66 - Aménagements ou adaptations d'appareils ou d'instruments, non prévus ailleurs
  • H01Q 1/44 - Détails de dispositifs associés aux antennes utilisant un équipement ayant une autre fonction principale servant en outre d'antenne
  • H01Q 21/22 - Réseaux d'unités d'antennes, de même polarisation, excitées individuellement et espacées entre elles les unités d'antennes du réseau étant excitées d'une façon non uniforme en amplitude ou en phase, p. ex. réseau à prises ou réseau bidirectionnel
  • H01Q 21/29 - Combinaisons d'unités d'antennes de types différents interagissant entre elles pour donner une caractéristique directionnelle désirée

13.

REGIMENS OF TAFENOQUINE FOR PREVENTION OF MALARIA IN MALARIA-NAIVE SUBJECTS

      
Numéro de document 02968694
Statut Délivré - en vigueur
Date de dépôt 2015-12-02
Date de disponibilité au public 2016-06-09
Date d'octroi 2023-06-13
Propriétaire
  • THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • 60 DEGREES PHARMACEUTICALS, LLC (USA)
Inventeur(s)
  • Jones, John P.
  • Shmuklarsky, Moshe
  • Budda, Balasubrahmanyam
  • Dow, Geoffrey S.
  • Smith, Bryan L.

Abrégé

Methods of prevention of symptomatic malaria in a malaria-naïve, G6PD-normal human subject comprising administering to the human subject a compound of Formula (I), a pharmaceutically acceptable salt thereof, or pharmaceutical composition comprising a compound of Formula (I). A compound of Formula (I) can be administered prior to potential exposure of a species of Plasmodium, during potential exposure of a species of Plasmodium, and after potential exposure of a species of Plasmodium. The methods of the invention also pertains to kits comprising specific doses of Formula (I), a pharmaceutically acceptable salt thereof, or pharmaceutical composition comprising a compound of Formula (I), and instructions for administration of dosing quantity and frequency. The methods of the invention also pertain to determining doses of Formula (I) that meet the general regulatory requirement for a drug to be efficacious in the prevention of malaria in malaria-naïve subjects. The methods of the invention further pertain to using the described algorithm to derive dosing regimens which can provide protection against symptomatic malaria in malaria-naïve, G6PD-normal subjects.

Classes IPC  ?

14.

A MECHANICAL TOURNIQUET APPARATUS AND METHOD OF USE

      
Numéro de document 03214534
Statut En instance
Date de dépôt 2014-09-29
Date de disponibilité au public 2015-04-02
Propriétaire
  • GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • ALPHAPOINTE (USA)
Inventeur(s)
  • Kosiorek, Christopher B.
  • Drayton, Dexter C.
  • Abir, Esra
  • Damar, Neslihan
  • Polat, Nilufer
  • Avci, Yavuz

Abrégé

ABSTRACTA pre-fabricated tourniquet that is easy to apply, that ensures consistent and even circumferential pressure, that is light weight, that provides standard life saving operation, and that can be utilized in any setting or situation, and related methods are provided. Mechanically constricting tourniquet apparatus and related methods are provided that are comprised of a tourniquet body, a carriage, a torsion bar, a receiver and a slider. The tourniquet is long enough to encircle a human limb, for example, an arm or leg.Date recue/Date received 2023-09-27

Classes IPC  ?

  • A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
  • A61B 17/132 - Tourniquets
  • A61B 90/00 - Instruments, outillage ou accessoires spécialement adaptés à la chirurgie ou au diagnostic non couverts par l'un des groupes , p. ex. pour le traitement de la luxation ou pour la protection de bords de blessures

15.

A MECHANICAL TOURNIQUET APPARATUS AND METHOD OF USE

      
Numéro de document 02929223
Statut Délivré - en vigueur
Date de dépôt 2014-09-29
Date de disponibilité au public 2015-04-02
Date d'octroi 2023-10-31
Propriétaire
  • GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • ALPHAPOINTE (USA)
Inventeur(s)
  • Kosiorek, Christopher B.
  • Abir, Esra
  • Damar, Neslihan
  • Polat, Nilufer
  • Avci, Yavuz
  • Drayton, Dexter C.

Abrégé

A pre-fabricated tourniquet that is easy to apply, that ensures consistent and even circumferential pressure, that is light weight, that provides standard life saving operation, and that can be utilized in any setting or situation, and related methods are provided. Mechanically constricting tourniquet apparatus and related methods are provided that are comprised of a tourniquet body, a carriage, a torsion bar, a receiver and a slider. The tourniquet is long enough to encircle a human limb, for example, an arm or leg.

Classes IPC  ?

16.

ESTIMATING CORE TEMPERATURES OF BATTERY CELLS IN A BATTERY PACK

      
Numéro de document 02874632
Statut Délivré - en vigueur
Date de dépôt 2013-05-23
Date de disponibilité au public 2013-11-28
Date d'octroi 2021-06-22
Propriétaire
  • UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (THE) (USA)
  • THE REGENTS OF THE UNIVERSITY OF MICHIGAN (USA)
Inventeur(s)
  • Lin, Xinfan
  • Stefanopoulou, Anna G.
  • Ding, Yi
  • Castanier, Matthew P.

Abrégé

A method and a system of estimating core temperatures of battery cells in a battery pack can include several steps. In one step, a surface temperature of one or more battery cell(s) is received, a current of the one or more battery cell(s) is received, an inlet temperature of coolant provided to the battery pack is received, and a flow rate or velocity of the coolant is received. In another step, estimations are made including those of a cell-lumped internal electrical resistance of the battery cell(s), a cell-lumped conduction resistance between a core and a surface of the battery cell(s), and a cell- lumped convection resistance between the surface and the coolant. In yet another step, an estimation is made of a core temperature of the battery cell(s) based upon the received and estimated values of previous steps.

Classes IPC  ?

  • H01M 10/48 - Accumulateurs combinés à des dispositions pour mesurer, tester ou indiquer l'état des éléments, p. ex. le niveau ou la densité de l'électrolyte

17.

CEMENT BASED ARMOR PANEL SYSTEM

      
Numéro de document 02716969
Statut Délivré - en vigueur
Date de dépôt 2009-02-27
Date de disponibilité au public 2009-09-11
Date d'octroi 2015-06-09
Propriétaire
  • UNITED STATES GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • Knauf Gips KG (USA)
Inventeur(s)
  • Tonyan, Timothy D.
  • Frank, William A.
  • Dubey, Ashish
  • Natesaiyer, Kumar
  • Durst, Bartley P.
  • Kinnebrew, Pamela G.
  • Cummins, Toney K.
  • Boone, Nicholas
  • Heard, William F.
  • Roth, Michael J.
  • Slawson, Thomas
  • Davis, James L.
  • Stinson, Ryan
  • Johnson, Carol F.

Abrégé

A cementitious armor panel assembly including cementitious armor panel with ballistic and blast resistant properties attached to a frame structure to produce a protective structure. The cementitious armor panels have a continuous phase resulting from the curing of an aqueous mixture of an inorganic cement binder, an inorganic mineral filler having a particle size of about 150-450 microns, a pozzolanic mineral filler, a polycarboxylate based super-plasticizer self-leveling agent, and water. The mixture may also contain alkanolamine, and acid or acid salt. Prior to curing, the continuous phase is reinforced with fiber uniformly distributed in the continuous phase before it is cured to form the panel. The panel may be reinforced with a skin attached to at least one surface of the panel.

Classes IPC  ?

  • C04B 28/28 - Compositions pour mortiers, béton ou pierre artificielle, contenant des liants inorganiques ou contenant le produit de réaction d'un liant inorganique et d'un liant organique, p. ex. contenant des ciments de polycarboxylates contenant des polyacides organiques, p. ex. contenant des ciments de polycarboxylates
  • F41H 5/02 - Structure des plaques
  • F41H 5/04 - Structure des plaques composées de plus d'une couche

18.

CEMENT BASED LAMINATED ARMOR PANELS

      
Numéro de document 02717506
Statut Délivré - en vigueur
Date de dépôt 2009-02-27
Date de disponibilité au public 2009-09-11
Date d'octroi 2015-11-24
Propriétaire
  • UNITED STATES GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • Knauf Gips KG (USA)
Inventeur(s)
  • Tonyan, Timothy D.
  • Frank, William A.
  • Dubey, Ashish
  • Chan, Cesar
  • Durst, Bartley P.
  • Kinnebrew, Pamela G.
  • Cummins, Toney K.
  • Boone, Nicholas
  • Heard, William F.
  • Roth, Michael J.
  • Davis, James L.

Abrégé

A cementitious panel with ballistic and blast resistant properties having a core layer of ultra-high compressive strength composite and at least one skin layer. The panels can also be used in walls, ceiling and flooring panels which require high compressive strength for resistance to earthquakes and surfaces resistant to surface abuse such as in prison and other institutions. The panel core layer has a continuous cementitious phase resulting from the curing of an aqueous mixture, in the absence of silica flour, of inorganic cement binder, inorganic mineral filler having a particle size of about 150-450 microns, a pozzolanic mineral filler, polycarboxylate based superplasticizer, alkanolamine and acid or alkali metal acid salt; and water. The mixture may be uniformly reinforced with fiber added before curing. The cementitious core layer is then reinforced with the skin, such as fiber reinforced polymer, attached to at least one panel surface.

Classes IPC  ?

  • B32B 7/12 - Liaison entre couches utilisant des adhésifs interposés ou des matériaux interposés ayant des propriétés adhésives
  • B32B 13/12 - Produits stratifiés composés essentiellement d'une substance à prise hydraulique, p. ex. du béton, du plâtre, du ciment, ou d'autres matériaux entrant dans la construction comprenant une telle substance comme seul composant ou composant principal d'une couche adjacente à une autre couche d'une substance spécifique de résine synthétique
  • B32B 13/14 - Produits stratifiés composés essentiellement d'une substance à prise hydraulique, p. ex. du béton, du plâtre, du ciment, ou d'autres matériaux entrant dans la construction adjacente à une couche fibreuse ou filamenteuse
  • F41H 5/04 - Structure des plaques composées de plus d'une couche

19.

A SELF-LEVELING CEMENTITIOUS COMPOSITION WITH CONTROLLED RATE OF STRENGTH DEVELOPMENT AND ULTRA-HIGH COMPRESSIVE STRENGTH UPON HARDENING AND ARTICLES MADE FROM SAME

      
Numéro de document 02717507
Statut Délivré - en vigueur
Date de dépôt 2009-02-27
Date de disponibilité au public 2009-09-11
Date d'octroi 2015-09-15
Propriétaire
  • UNITED STATES GOVERNMENT, REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • Knauf Gips KG (USA)
Inventeur(s)
  • Dubey, Ashish
  • Chan, Cesar
  • Natesaiyer, Kumar
  • Durst, Bartley P.
  • Kinnebrew, Pamela G.
  • Cummins, Toney K.
  • Boone, Nicholas
  • Heard, William F.
  • Roth, Michael J.
  • Slawson, Thomas

Abrégé

A self-leveling cementitious mixture with excellent flow properties and which hardens with a controlled rate of strength development to an ultra-high compressive strength composite composition for use in making articles such as cementitious armor panel with ballistic and blast resistant properties including: a continuous phase resulting from the curing of an aqueous mixture, in the absence of silica flour, of inorganic cement binder, inorganic mineral filler having a particle size of about 150-450 microns, pozzolanic mineral filler, polycarboxylate based self-leveling agent and water. The cementitious mixture may include alkanolamine, such as thethanolamine, and acid or acid salt, such as tartaric acid. The cementitious composition may be reinforced with reinforcing fibers, e.g. glass fibers, in an amount of about 0.5 - 6.0 % by volume of the overall cementitious composition. The fibers are uniformly dispersed in the cementitious composition before it is cured to form a final cementitious armor panel.

Classes IPC  ?

  • C04B 14/02 - Matières granuleuses
  • C04B 14/38 - Matières fibreuses"Whiskers"
  • C04B 28/00 - Compositions pour mortiers, béton ou pierre artificielle, contenant des liants inorganiques ou contenant le produit de réaction d'un liant inorganique et d'un liant organique, p. ex. contenant des ciments de polycarboxylates

20.

TRAUMA TRAINING SYSTEM

      
Numéro de document 02650540
Statut Délivré - en vigueur
Date de dépôt 2007-04-24
Date de disponibilité au public 2007-11-08
Date d'octroi 2015-06-16
Propriétaire U.S. GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventeur(s) King, Lynn R.

Abrégé

A system for simulating one or more hemorrhages in order to provide a more dynamic and realistic hemorrhage simulation in order to train medical personnel and other critical care givers, such as first responders, medics, and emergency medical technicians (EMTs) on treating hemorrhages. The system includes a reservoir, a flow controller, and at least one conduit connected to at least one simulated wound site wherein the system supplies fluid to the simulated wound site in order to simulate a hemorrhage. The system may further include a plurality of wound sites that have their respective fluid flows controlled by the fluid flow controller. In at least one embodiment, the reservoir and the flow controller are housed within a bag. In at least one embodiment, the system further includes an audio system for providing audio cues to the simulation participants to enhance the realism of the simulation.

Classes IPC  ?